University of Michigan researchers are identifying opportunities to treat rare eye cancers with new targeted therapies being used for other types of cancer.

A University of Michigan study suggests attacking pancreatic cancer cells' metabolism could help fight the cancer. Learn what enzyme is being targeted.

Researchers at the University of Michigan have identified a promising new drug compound, UM-164, for treating triple-negative breast cancer.

A review shows that involving a medical and surgical oncologist from the beginning of treatment could extend survival in colorectal liver metastases. Learn how.

Research suggests immune T cells help reverse chemotherapy resistance in ovarian cancer. See how immunotherapy drugs could play an important role in treatment.

African-Americans diagnosed with colorectal cancer at a young age had worse outcomes compared to other patients. Learn what could be causing the disparity.

Vessel-sparing radiation combined with a better understanding of prostate anatomy is helping doctors treat prostate cancer while minimizing side effects.

Study shows the bacteria P. gingivalis is present in the esophagus in 61 percent of patients with squamous cell esophageal cancer. Here's more on the study.

After a colorectal cancer patient finishes treatment, primary care doctors are being called to play a key role in their recovery and overall continued heath.

New medical research from the University of Michigan explores how a patient’s own immune system might help determine effective treatment options for cancer.

A University of Michigan Comprehensive Cancer Center study found 25 percent of low-risk patients substantially overestimated their risk of distant recurrence.